⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2550303 | 0.70 | — | — | |
| SCHEMBL12643175 | 0.70 | — | — | |
| SCHEMBL25140691 | 0.69 | — | — | |
| SCHEMBL26187391 | 0.69 | — | — | |
| Tulipaline A SCHEMBL9054186 | 0.69 | ALDH1A1 (0.47) | — | |
| Tulipaline A SCHEMBL27750241 | 0.67 | — | — | |
| SCHEMBL24713199 | 0.62 | — | — | |
| SCHEMBL23519538 | 0.62 | — | — | |
| SCHEMBL13772951 | 0.58 | — | — | |
| SCHEMBL10333176 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993019739-A1 | VISCOUS SUSPENSIONS OF CONTROLLED-RELEASE DRUG PARTICLES | ALZA CORPORATION (US) | 1993-10-14 | — | — | WO | claimed |
| US-20240246291-A1 | Laminates and 3D Printers | VICI TRANSITION, INC., (US) | 2024-07-25 | — | — | US | disclosed |
| WO-2024026129-A2 | TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF | ENSEM THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2023064586-A1 | NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF | TANGO THERAPEUTICS, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| US-20190112305-A1 | BONE MARROW ON X CHROMOSOME KINASE (BMX) INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2019-04-18 | — | — | US | disclosed |
| US-10041001-B2 | Liquid crystal composition, liquid crystal display device including the same, and method of manufacturing liquid crystal display device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| US-10000483-B2 | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| US-10000483-B2 | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| US-20180086981-A1 | LIQUID CRYSTAL COMPOSITION AND DISPLAY DEVICE INCLUDING THE SAME | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2018-03-29 | — | — | US | disclosed |
| US-20180059487-A1 | LIQUID CRYSTAL COMPOSITION, DISPLAY DEVICE USING THE SAME, AND METHOD OF MANUFACTURING DISPLAY DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
| US-20170292074-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-12 | — | — | US | disclosed |
| US-20170210994-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME, AND METHOD OF MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
| US-20170210993-A1 | LIQUID CRYSTAL COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE INCLUDING THE SAME, AND METHOD OF MANUFACTURING LIQUID CRYSTAL DISPLAY DEVICE | TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD. (CN) | 2017-07-27 | — | — | US | disclosed |
| US-20150246913-A1 | BONE MARROW ON X CHROMOSOME KINASE (BMX) INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2015-09-03 | — | — | US | disclosed |
| US-20150246913-A1 | BONE MARROW ON X CHROMOSOME KINASE (BMX) INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2015-09-03 | — | — | US | disclosed |
| EP-1222174-B1 | IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE | TAKEDA PHARMACEUTICAL (JP) | 2009-05-27 | — | — | EP | disclosed |
| US-20070054892-A1 | Isoquinoline potassium channel inhibitors | MERCK SHARP & DOHME CORP. | 2007-03-08 | — | — | US | disclosed |
| EP-0392803-B1 | Novel compounds | BEECHAM GROUP PLC (GB) | 2004-06-16 | — | — | EP | disclosed |
| EP-0052916-B1 | ERODIBLE POLYMER CONTAINING EROSION RATE MODIFIER | ALZA CORPORATION (US) | 1985-01-02 | — | — | EP | disclosed |